Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 1:21 pm Sale |
2024-09-30 | 13G | Agile Therapeutics, Inc. AGRX |
Beryl Capital Management LLC | 0 0.000% |
-680,000 (Position Closed) |
Filing History |
| 2024-08-26 4:47 pm Purchase |
2024-08-06 | 13G | Agile Therapeutics, Inc. AGRX |
Mastrangeli Doug | 350,000 5.100% |
350,000 (New Position) |
Filing History |
| 2024-07-22 4:50 pm Purchase |
2024-07-10 | 13G | Agile Therapeutics, Inc. AGRX |
TANG CAPITAL PARTNERS LP | 426,153 6.200% |
426,153 (New Position) |
Filing History |
| 2024-07-09 2:20 pm Purchase |
2024-06-26 | 13G | Agile Therapeutics, Inc. AGRX |
Beryl Capital Management LLC | 680,000 9.900% |
680,000 (New Position) |
Filing History |
| 2024-07-02 3:44 pm Purchase |
2024-06-26 | 13G | Agile Therapeutics, Inc. AGRX |
Klein Roger M. | 618,000 9.000% |
618,000 (New Position) |
Filing History |
| 2024-02-13 8:02 pm Purchase |
2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Lind Global Fund II LP | 44,750 1.800% |
44,750 (New Position) |
Filing History |
| 2024-02-06 10:14 am Purchase |
2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 23,961 0.900% |
23,961 (New Position) |
Filing History |
| 2023-02-14 2:31 pm Unchanged |
2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-13 4:33 pm Purchase |
2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Lind Global Fund II LP | 89,195 9.900% |
24,191 (+37.21%) |
Filing History |
| 2023-02-08 06:06 am Sale |
2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 54,600 6.300% |
-14,007 (-20.42%) |
Filing History |
| 2022-07-12 5:00 pm Purchase |
2022-07-06 | 13G | Agile Therapeutics, Inc. AGRX |
Lind Global Fund II LP | 65,004 9.900% |
65,004 (New Position) |
Filing History |
| 2022-07-11 06:06 am Purchase |
2022-07-01 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 68,607 9.990% |
68,607 (New Position) |
Filing History |
| 2022-02-14 3:57 pm Purchase |
2021-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
PERCEPTIVE ADVISORS LLC | 10,647 17.500% |
2,687 (+33.76%) |
Filing History |
| 2022-02-09 3:16 pm Purchase |
2021-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
The Vanguard Group | 2,247 3.700% |
61 (+2.79%) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Agile Therapeutics, Inc. AGRX |
BLACKROCK INC BLK |
654 1.500% |
-1,907 (-74.45%) |
Filing History |
| 2021-02-16 3:54 pm Purchase |
2020-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
PERCEPTIVE ADVISORS LLC | 7,960 18.200% |
2,000 (+33.56%) |
Filing History |
| 2021-02-10 3:17 pm Sale |
2020-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Renaissance Technologies LLC | 0 0.000% |
-1,633 (Position Closed) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
The Vanguard Group | 2,186 5.000% |
2,186 (New Position) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
BLACKROCK INC BLK |
2,561 5.900% |
2,561 (New Position) |
Filing History |
| 2020-10-01 4:25 pm Sale |
2020-09-18 | 13D | Agile Therapeutics, Inc. AGRX |
ProQuest Investments III L.P. | 2,110 4.800% |
-421 (-16.64%) |
Filing History |